Loading...
XNAS
SOPH
Market cap378mUSD
Jul 09, Last price  
5.82USD
1D
5.63%
1Q
23.83%
IPO
-65.76%
Name

Sophia Genetics SA

Chart & Performance

D1W1MN
XNAS:SOPH chart
P/E
—
P/S
5.18
EPS
—
Div Yield, %
—
Shrs. gr., 5y
7.06%
Rev. gr., 5y
22.16%
Revenues
77m
+18.56%
25,362,00028,400,00040,450,00047,560,00062,371,00065,173,00077,271,000
Net income
-79m
L+26.41%
-33,791,000-39,339,000-73,675,000-87,449,000-78,981,000-62,493,000-78,999,000
CFO
-38m
L-11.23%
-31,680,000-31,730,000-57,939,000-70,093,000-48,575,000-42,822,000-38,011,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
URL
https://www.sophiagenetics.com/
IPO date
Jul 23, 2021
Employees
466
Domiciled in
CH
Incorporated in
CH

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT